This article is more than 5 years old. Information may no longer be current.
DSM Biomedical announces continued partnership with Spinelab
Click Here to Manage Email Alerts
DSM Biomedical, announced it has extended its partnership with Spinelab Ltd., a privately held company specializes in developing a dynamic stabilization system for the spine, according to a company press release.
Spinelab’s Elaspine Implant System is a pedicle-screw based posterior motion preservation system for the degenerative lumbar spine, uses Bionate PCU, a proprietary DSM Biomedical polymer with optional built-in surface modification. It is designed for chronic implants and extensively used in orthopedic applications for its tough load-bearing qualities, according to the press release. The implant system marks the first clinical use of a PCU-only posterior rod which allows the system to act comparably to a damper thus enhancing stability and reducing the effects of peak loads.
”Continuing to evolve our relationship with DSM Biomedical puts us in a unique position to leverage the impressive track record of their suite of biomedical materials” Thomas Zehnder, president and CEO, Spinelab, stated in the release. “We selected Bionate PCU for its long and successful clinical track record. Working with a proven, unmatched implantable material for our spinal applications allows Spinelab to focus on delivering the desired biomechanics to ensure implant performance for our esteemed customers.”